Nova Financial Statements From 2010 to 2024
| NMLSF Stock | USD 0.03 0 6.14% |
Check Nova Mentis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nova Mentis' main balance sheet or income statement drivers, such as , as well as many indicators such as . Nova financial statements analysis is a perfect complement when working with Nova Mentis Valuation or Volatility modules.
Nova |
Nova Mentis Life Company Return On Equity Analysis
Nova Mentis' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Nova Mentis Return On Equity | -0.89 |
Most of Nova Mentis' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Mentis Life is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Nova Mentis Life has a Return On Equity of -0.8948. This is 96.27% lower than that of the Healthcare sector and 97.55% lower than that of the Biotechnology industry. The return on equity for all United States stocks is 188.65% higher than that of the company.
Nova Mentis Life Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nova Mentis's current stock value. Our valuation model uses many indicators to compare Nova Mentis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nova Mentis competition to find correlations between indicators driving Nova Mentis's intrinsic value. More Info.Nova Mentis Life is regarded third in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nova Mentis' earnings, one of the primary drivers of an investment's value.About Nova Mentis Financial Statements
Nova Mentis stakeholders use historical fundamental indicators, such as Nova Mentis' revenue or net income, to determine how well the company is positioned to perform in the future. Although Nova Mentis investors may analyze each financial statement separately, they are all interrelated. For example, changes in Nova Mentis' assets and liabilities are reflected in the revenues and expenses on Nova Mentis' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Nova Mentis Life. Please read more on our technical analysis and fundamental analysis pages.
Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therapeutics for neuroinflammatory conditions with a focus on autism spectrum disorder and fragile X syndrome in Canada. Nova Mentis Life Science Corp. was incorporated in 2004 and is headquartered in Vancouver, Canada. Nova Mentis is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova Pink Sheet
Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.